Panagiotis G. Asteris, Danial J. Armaghani, Amir H. Gandomi, Ahmed Salih Mohammed, Zoi Bousiou, Ioannis Batsis, Nikolaos Spyridis, Georgios Karavalakis, Anna Vardi, Markos Z. Tsoukals, Leonidas Triantafyllidis, Evangelos I. Koutras, Nikos Zygouris, Georgios A. Drosopoulos, Leonidas Dritsas, Nikolaos A. Fountas, Nikolaos M. Vaxevanidis, Abidhan Bardhan, Pijush Samui, George D. Hatzigeorgiou, Jian Zhou, Konstantina V. Leontari, Paschalis Evangelidis, Nikolaos Kotsiou, Ioanna Sakellari, Eleni Gavriilaki
{"title":"Survival Prediction in Allogeneic Haematopoietic Stem Cell Transplant Recipients Using Pre- and Post-Transplant Factors and Computational Intelligence","authors":"Panagiotis G. Asteris, Danial J. Armaghani, Amir H. Gandomi, Ahmed Salih Mohammed, Zoi Bousiou, Ioannis Batsis, Nikolaos Spyridis, Georgios Karavalakis, Anna Vardi, Markos Z. Tsoukals, Leonidas Triantafyllidis, Evangelos I. Koutras, Nikos Zygouris, Georgios A. Drosopoulos, Leonidas Dritsas, Nikolaos A. Fountas, Nikolaos M. Vaxevanidis, Abidhan Bardhan, Pijush Samui, George D. Hatzigeorgiou, Jian Zhou, Konstantina V. Leontari, Paschalis Evangelidis, Nikolaos Kotsiou, Ioanna Sakellari, Eleni Gavriilaki","doi":"10.1111/jcmm.70672","DOIUrl":null,"url":null,"abstract":"<p>Advancements in artificial intelligence (AI) predictive models have emerged as valuable tools for predicting survival outcomes in allogeneic haematopoietic stem cell transplantation (allo-HSCT). These models primarily focus on pre-transplant factors, while algorithms incorporating changes in patient's status post-allo-HSCT are lacking. The aim of this study was to develop a predictive soft computing model assessing survival outcomes in allo-HSCT recipients. In this study, we assembled a comprehensive database comprising of 564 consecutive adult patients who underwent allo-HSCT between 2015 and 2024. Our algorithm selectively considers critical parameters from the database, ranking and evaluating them based on their impact on patient outcomes. By utilising the Data Ensemble Refinement Greedy Algorithm, we developed an AI model with 93.26% accuracy in predicting survivorship status in allo-HSCT recipients. Our model used only seven parameters, including age, disease, disease phase, creatinine levels at day 2 post-allo-HSCT, platelet engraftment, acute graft-versus-host disease (GvHD) and chronic GvHD. External validation of our AI model is considered essential. Machine learning algorithms have the potential to improve the prediction of long-term survival outcomes for patients undergoing allo-HSCT.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 16","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70672","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Advancements in artificial intelligence (AI) predictive models have emerged as valuable tools for predicting survival outcomes in allogeneic haematopoietic stem cell transplantation (allo-HSCT). These models primarily focus on pre-transplant factors, while algorithms incorporating changes in patient's status post-allo-HSCT are lacking. The aim of this study was to develop a predictive soft computing model assessing survival outcomes in allo-HSCT recipients. In this study, we assembled a comprehensive database comprising of 564 consecutive adult patients who underwent allo-HSCT between 2015 and 2024. Our algorithm selectively considers critical parameters from the database, ranking and evaluating them based on their impact on patient outcomes. By utilising the Data Ensemble Refinement Greedy Algorithm, we developed an AI model with 93.26% accuracy in predicting survivorship status in allo-HSCT recipients. Our model used only seven parameters, including age, disease, disease phase, creatinine levels at day 2 post-allo-HSCT, platelet engraftment, acute graft-versus-host disease (GvHD) and chronic GvHD. External validation of our AI model is considered essential. Machine learning algorithms have the potential to improve the prediction of long-term survival outcomes for patients undergoing allo-HSCT.
期刊介绍:
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.